Literature DB >> 8203867

Determination of pefloxacin concentration in mesenteric lymph nodes by high-performance chromatography.

M I Munera1, F Cuesta, A Abadia, J Vasquez, M Restrepo.   

Abstract

Ten patients who had undergone laparotomies for different abdominal pathological conditions were studied to determine the levels of pefloxacin in mesenteric lymph nodes. Each patient was given 400 mg of oral pefloxacin every 12 h for the 3 days prior to surgery. Drug levels in tissue were determined by high-pressure liquid chromatography (reverse phase); the mean +/- standard deviation was 17.1 +/- 11.9 micrograms/g, with a range of 2.12 to 36.6 micrograms/g. This indicates an adequate pefloxacin concentration in lymph nodes and makes the drug a good option for the treatment of conditions in which lymph nodes act as an infection-promoting and/or relapse-favoring factor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8203867      PMCID: PMC284512          DOI: 10.1128/AAC.38.3.632

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

Review 1.  Tissue penetration of the new quinolones in humans.

Authors:  D N Gerding; J A Hitt
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

2.  The diffusion of pefloxacin into bone and the treatment of osteomyelitis.

Authors:  P Dellamonica; E Bernard; H Etesse; R Garraffo
Journal:  J Antimicrob Chemother       Date:  1986-04       Impact factor: 5.790

3.  Improved high-performance liquid chromatographic determination of pefloxacin and its metabolite norfloxacin in human plasma and tissue.

Authors:  G Montay; J P Tassel
Journal:  J Chromatogr       Date:  1985-04-12

4.  [Postoperative infection in ORL oncologic surgery. The choice of preventive antibiotherapy. Experience of the ORL Department of Hôpital Claude Bernard].

Authors:  P Gehanno; J Depondt; F Véber; C Guédon; N Moisy
Journal:  Ann Otolaryngol Chir Cervicofac       Date:  1985

5.  Uptake of antibiotics by human alveolar macrophages.

Authors:  W L Hand; R W Corwin; T H Steinberg; G D Grossman
Journal:  Am Rev Respir Dis       Date:  1984-06

Review 6.  Use of fluoroquinolones for intracellular pathogens.

Authors:  J J Pocidalo
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

7.  Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans.

Authors:  G Montay; Y Goueffon; F Roquet
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

Review 8.  Fluoroquinolones in the treatment of typhoid fever and the carrier state.

Authors:  I Zavala Trujillo; C Quiroz; M A Gutierrez; J Arias; M Renteria
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 9.  Pharmacokinetics of quinolones: newer aspects.

Authors:  J S Wolfson; D C Hooper
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

10.  Penetration of pefloxacin in human heart valves.

Authors:  N Brion; A Lessana; F Mosset; J J Lefevre; G Montay
Journal:  J Antimicrob Chemother       Date:  1986-04       Impact factor: 5.790

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.